YouthBio Therapeutics
Organization Description
Founded by investors Yuri Deigin and Viet Ly and with Dr. João Pedro de Magalhães as its Chief Scientific Officer, YouthBio Therapeutics focuses on gene therapies that induce epigenetic rejvuenation. The company has exited stealth mode as of April 14, 2022 and has not yet announced the full details of its upcoming therapies.
Team
Yuri Deigin
YouthBio Therapeutics - Co-Founder and Director
Related News
May 13, 2022
Professor João Pedro de Magalhães leads the Genomics of Ageing and Rejuvenation Lab at the Institute of Inflammation and Ageing in the University of Birmingham. He is also CSO of YouthBio Therapeutics, a US-based biotech company that develops rejuvenation gene therapies based on partial reprogramming by Yamanaka factors. Last year, he co-authored The hoverfly and...